Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Study explores how CAR T immunotherapy could be used to treat solid tumors

Study explores how CAR T immunotherapy could be used to treat solid tumors

New study provides comparative analysis of twelve COVID-19 vaccines

New study provides comparative analysis of twelve COVID-19 vaccines

Beneficial effects of gene therapy can be seen in SCID-X1 patients decades after treatment

Beneficial effects of gene therapy can be seen in SCID-X1 patients decades after treatment

New approach could treat infertility caused by abnormal GnRH secretion

New approach could treat infertility caused by abnormal GnRH secretion

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Could measles virus vectors be used for a new COVID-19 vaccine?

Could measles virus vectors be used for a new COVID-19 vaccine?

Viruses can use freshwater sources as vector for transmission, study suggests

Viruses can use freshwater sources as vector for transmission, study suggests

Cell-selective nanotherapy can help treat atherosclerotic plaques

Cell-selective nanotherapy can help treat atherosclerotic plaques

CRISPR genomic editing to obtain more productive and nutritive plant varieties

CRISPR genomic editing to obtain more productive and nutritive plant varieties

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

COVID-19 vaccine should be recommended to patients with Parkinson’s disease, experts say

COVID-19 vaccine should be recommended to patients with Parkinson’s disease, experts say

One dose of VSV-vectored vaccine prevents SARS-CoV-2 replication in hamsters

One dose of VSV-vectored vaccine prevents SARS-CoV-2 replication in hamsters

ZyCoV-D DNA vaccine immunogenic against SARS-CoV-2 in animal models

ZyCoV-D DNA vaccine immunogenic against SARS-CoV-2 in animal models